Orange Book product · Generic (ANDA)
FLUPHENAZINE DECANOATE
FLUPHENAZINE DECANOATE
At a glance
Jul 14, 1987
Approved
Generic (ANDA)
Application
AO
TE code
None
Listed patents
Key dates
Approval
FDA approval date of this drug product.
Jul 14, 1987
39 yr 6 mo ago
Today
Pharmaceutical detail
Active ingredient
FLUPHENAZINE DECANOATE
Strength
25MG/ML
Dosage form
INJECTABLE
Route
INJECTION
TE code
AO
Application
ANDA 071413
Product number
001
Marketing status
RX
Reference listed drug (RLD)
No
Reference standard (RS)
Yes
Active-ingredient family
View full familyGeneric (ANDA) of FLUPHENAZINE DECANOATE
- —PROLIXIN DECANOATEBrand (NDA)
NDA 016727 · BRISTOL MYERS SQUIBB
- 2023FLUPHENAZINE DECANOATEGeneric (ANDA)
ANDA 215365 · MSN
- 2023FLUPHENAZINE DECANOATEGeneric (ANDA)
ANDA 215509 · GLAND
- 2017FLUPHENAZINE DECANOATEGeneric (ANDA)
ANDA 207739 · EUGIA PHARMA
- 2014FLUPHENAZINE DECANOATEGeneric (ANDA)
ANDA 203732 · PH HEALTH
- 2001FLUPHENAZINE DECANOATEGeneric (ANDA)
ANDA 075918 · MYLAN LABS LTD
- 1998FLUPHENAZINE DECANOATEGeneric (ANDA)
ANDA 074966 · HOSPIRA
- 1996FLUPHENAZINE DECANOATEGeneric (ANDA)
ANDA 074795 · TEVA PARENTERAL
- 1996FLUPHENAZINE DECANOATEGeneric (ANDA)
ANDA 074531 · HIKMA
Listed patents
No patents are listed against this product in the Orange Book. Listed patents reflect those the NDA holder submits under 21 U.S.C. 355 and are not exhaustive.
